Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 4/2005

01-04-2005 | Editorial

Chromovitrectomy: a new field in vitreoretinal surgery

Authors: Eduardo B. Rodrigues, Carsten H. Meyer, Peter Kroll

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 4/2005

Login to get access

Excerpt

Staining tissues during vitreo-retinal surgery, “chromovitrectomy”, has become a popular approach to visualize preretinal structures. Initially, Burk et al. described in 2000 the intravitreal administration of indocyanine green (ICG) to stain the internal limiting membrane (ILM) [3]. There is general agreement that ICG-assisted ILM peeling is then much facilitated, as the surgeon can easily observe the edge of the ILM rhexis thus ensuring a complete ILM removal. Consequently, trypan blue (TB) arose as the second-generation of vital dyes for chromovitrectomy [24]. Currently, triamcinolone acetonide (TA) has been added as an alternative stain for chromovitrectomy [21]. The rationale for chromovitrectomy is simple, as most preretinal structures have a semitransparent appearance. Over 90 controversial reports have been published on chromovitrectomy in the last 4 years [18]. …
Literature
1.
Acosta MM, Boyce HW (1998) Chromoendoscopy—where is it useful? J Clin Gastroenterol 27:13–20
2.
Bhisitkul RB (2003) Second generation vital stains in retinal surgery. Br J Ophthalmol 87:664–665CrossRefPubMed
3.
Burk SE, Da Mata AP, Snyder ME et al (2000) Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 107:2010–2014CrossRefPubMed
4.
Czajka MP, McCuen BW, Cummings TJ et al (2004) Effects of indocyanine green on the retina and retinal pigment epithelium in a porcine model of retinal hole. Retina 24:275–2822CrossRefPubMed
5.
Feron EJ, Veckeneer M, Parys-Van Ginderdeuren R et al (2002) Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy. Arch Ophthalmol 120:141–144PubMed
6.
Gandorfer A, Haritoglou C, Gandorfer A, Kampik A (2003) Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci 44:316–323CrossRefPubMed
7.
Gass CA, Haritoglou C, Schaumberger M, Kampik A (2003) Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 241:716–720
8.
Gifford H (1940) Use of fluorescein intravenously as an aid to ophthalmic diagnosis and treatment. Arch Ophthalmol 24:122–131
9.
Grisanti S, Szurman P, Gelisken F et al (2004) Histological findings in experimental macular surgery with indocyanine green. Invest Ophthalmol Vis Sci 45:282–286CrossRefPubMed
10.
Haritoglou C, Gandorfer A, Gass CA et al (2002) Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol 134:836–841CrossRefPubMed
11.
Iriyama A, Uchida S, Yanagi Y et al (2004) Effects of indocyanine green on retinal ganglion cells. Invest Ophthalmol Vis Sci 45:943–947CrossRefPubMed
12.
Kutschera E (1969) Vital staining of the detached retina with retinal breaks. Albrecht Von Graefes Arch Klin Exp Ophthalmol 178:72–87PubMed
13.
Lochhead J, Jones E, Chui D et al (2004) Outcome of ICG-assisted ILM peel in macular hole surgery. Eye 18:804–808CrossRefPubMed
14.
Maia M, Kellner L, de Juan E et al (2004) Effects of indocyanine green injection on the retinal surface and into the subretinal space in rabbits. Retina 24:80–91PubMed
15.
Mennel S, Meyer CH, Rodrigues EB, Schmidt JC, Kroll P (2004) Patent blue (Blueron) a new dye for cataract surgery and chromovitrectomy. [Abstract]. Ophthalmologe (in press)
16.
Meyer CH, Rodrigues EB, Kroll P (2004) “VINCE” a new applicator of vital dyes for a selective staining of preretinal structures during chromovitrectomy. XXIVth Meeting of the Club Jules Gonin. Vouliagmeni, Athens, Greece. p 23
17.
Olliver JR, Wild CP, Sahay P et al (2003) Chromoendoscopy with methylene blue and associated DNA damage in Barrett’s esophagus. Lancet 362:373–374CrossRefPubMed
18.
Rodrigues EB, Meyer CH (2004) Chromovitrectomy. App. 7th Vitreoretinal Symposium. Marburg, Germany, 2004, pp 21
19.
Rodrigues EB, Meyer CH, Schmidt JC, Kroll P (2003) Trypan blue stains the epiretinal membrane but not the internal limiting membrane [correspondence]. Br J Ophthalmol 87:1431–1432CrossRef
20.
Rodrigues EB, Meyer CH, Tietjen A, Kroll P (2004) Alternative stains for chromovitrectomy [abstract]. Ophthalmologe (in press)
21.
Roth DB, Chieh J, Spirn MJ et al (2003) Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 121:1279–1282CrossRefPubMed
22.
Sorsby A (1939) Vital staining of the fundus. Trans Ophthal Soc UK 59:727–730
23.
Szurmann P, Grisanti S, Schraermeyer U et al (2001) Indocyanine green staining of internal limiting membrane in vitreoretinal surgery [abstract]. Invest Ophthalmol Vis Sci 42(Suppl):S688
24.
Veckeneer M, van Overdam K, Monzer J et al (2001) Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes. Graefes Arch Clin Exp Ophthalmol 239:698–704PubMed
25.
Weinberger AWA, Schlossmacher B, Dahlke C et al (2002) Indocyanine-green-assisted internal limiting membrane peeling in macular hole surgery—a follow-up study. Graefes Arch Clin Exp Ophthalmol 240:913–917PubMed
Metadata
Title
Chromovitrectomy: a new field in vitreoretinal surgery
Authors
Eduardo B. Rodrigues
Carsten H. Meyer
Peter Kroll
Publication date
01-04-2005
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 4/2005
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-004-0992-x

Other articles of this Issue 4/2005

Graefe's Archive for Clinical and Experimental Ophthalmology 4/2005 Go to the issue

Laboratory Investigation

Influence on membrane-mediated cell activation by vesicles of silicone oil or perfluorohexyloctane

Clinical Investigation

Correction of pre-existing astigmatism during cataract surgery: comparison between the effects of opposite clear corneal incisions and a single clear corneal incision

Clinical Investigation

May glutathione S-transferase M1 positive genotype afford protection against primary open-angle glaucoma?

Clinical Investigation

An assessment of the pattern of spontaneous eyeblink activity under the influence of topical ocular anaesthesia

Clinical Investigation

Associations between the deletion polymorphism of the angiotensin 1-converting enzyme gene and ocular signs of primary open-angle glaucoma

Short Communication

Diagnostic value of mitochondrial DNA mutation analysis in juvenile unilateral ptosis